URSO, LOREDANA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.080
EU - Europa 247
AS - Asia 129
Totale 2.456
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.072
IT - Italia 109
CN - Cina 104
SE - Svezia 56
FI - Finlandia 31
DE - Germania 17
GB - Regno Unito 15
IN - India 13
FR - Francia 10
CA - Canada 8
VN - Vietnam 5
TW - Taiwan 4
UA - Ucraina 4
IE - Irlanda 2
NL - Olanda 2
CZ - Repubblica Ceca 1
HK - Hong Kong 1
JP - Giappone 1
PH - Filippine 1
Totale 2.456
Salva come PNG Salva come JPEG
Città #
Fairfield 451
Chandler 206
Woodbridge 173
Ashburn 163
Houston 139
Cambridge 133
Seattle 124
Wilmington 111
San Diego 98
Ann Arbor 59
Padova 42
Medford 39
Princeton 39
Guangzhou 34
Helsinki 27
Des Moines 25
Roxbury 21
Beijing 18
New York 12
Shanghai 12
Boardman 9
Nanjing 8
Ottawa 8
Milan 7
Nanchang 6
Ogden 6
Paris 6
Dong Ket 5
London 5
Hsinchu County 4
Kharkiv 4
Selvazzano Dentro 4
Changsha 3
Los Angeles 3
Norwalk 3
Washington 3
Acton 2
Bitonto 2
Castagnole 2
Columbus 2
Dublin 2
Geislingen an der Steige 2
Genoa 2
Hebei 2
Kunming 2
Nepi 2
Pune 2
Redmond 2
Redwood City 2
Shenyang 2
Treviso 2
Zhengzhou 2
Amsterdam 1
Borås 1
Bresso 1
Cagliari 1
Caloocan City 1
Camparada 1
Chiswick 1
Chongqing 1
Falkenstein 1
Forlì 1
Hefei 1
Hounslow 1
Jiaxing 1
Kilburn 1
Lecce 1
Legnaro 1
Mumbai 1
Orange 1
Phoenix 1
Portland 1
Prague 1
Quzhou 1
Rome 1
San Mateo 1
Tianjin 1
Verona 1
Xian 1
Totale 2.069
Salva come PNG Salva come JPEG
Nome #
De-escalated therapy for HR+/HER2+ breast cancer patients with Ki67 response after 2 weeks letrozole: results of the PerELISA neoadjuvant study 178
211P: Inflammatory cells characterization and localization in malignant pleural mesothelioma (MPM) tissue samples: Correlation with histologic subtype and prognosis 171
Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intra-tumor heterogeneity over time 122
Synergistic Antitumor Activity of Recombinant Human Apo2L/Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL) in Combination with Carboplatin and Pemetrexed in Malignant Pleural Mesothelioma 113
Synergistic targeting of malignant pleural mesothelioma cells by MDM2 inhibitors and TRAIL agonists 108
Metabolic rewiring and redox alterations in malignant pleural mesothelioma 95
MDM2 and HIF1alpha expression levels in different histologic subtypes of malignant pleural mesothelioma: Correlation with pathological and clinical data 87
Effects of sulfonylureas on tumor growth: A review of the literature 78
Critical review about MDM2 in cancer: Possible role in malignant mesothelioma and implications for treatment 76
Clinical Features and Progression Pattern of Acquired T790M-positive Compared With T790M-negative EGFR Mutant Non–small-cell Lung Cancer: Catching Tumor and Clinical Heterogeneity Over Time Through Liquid Biopsy 76
Synergistic antitumor activity of recombinant human Apo2L/Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in combination with carboplatin and pemetrexed in malignant pleural mesothelioma 76
Liquid biopsy in malignant pleural mesothelioma: State of the art, pitfalls, and perspectives 74
Epirubicin plus paclitaxel regimen as second-line treatment of patients with small-cell lung cancer 72
Combined Immunoscore for Prognostic Stratification of Early Stage Non-Small-Cell Lung Cancer 68
Clinical features and progression pattern of T790M+ compared with T790M-EGFR mutant NSCLC 64
Functions of epidermal growth factor receptor in cisplatin response of thyroid cells 62
ESR1 Gene Mutation in Hormone Receptor-Positive HER2-Negative Metastatic Breast Cancer Patients: Concordance Between Tumor Tissue and Circulating Tumor DNA Analysis 61
Cisplatin reduces endothelial cell migration via regulation of type 2-matrix metalloproteinase activity 58
Angiotensin II induces MMP 2 activity via FAK/JNK pathway in human endothelial cells 57
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation 57
Effects of cisplatin on matrix metalloproteinase-2 in transformed thyroid cells 55
Differential response of normal, dedifferentiated and transformed thyroid cell lines to cisplatin treatment 54
miR-212 increases tumor necrosis factor-related apoptosis-inducing ligand sensitivity in non-small cell lung cancer by targeting the antiapoptotic protein PED 49
Detection of circulating immunosuppressive cytokines in malignant pleural mesothelioma patients for prognostic stratification 48
Epigenetic Regulation of miR-212 Expression in Lung Cancer 44
PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype 44
Differential functions of PKC-delta and PKC-zeta in cisplatin response of normal and transformed thyroid cells 44
The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers 42
New platinum(II) complexes containing both an O,O′-chelated acetylacetonate ligand and a sulfur ligand in the platinum coordination sphere induce apoptosis in HeLa cervical carcinoma cells 39
Sublethal concentrations of the platinum(II) complex [Pt(O,O′-acac) (γ-acac)(DMS)] alter the motility and induce anoikis in MCF-7 cells 37
Anti-apoptotic effects of protein kinase C-δ and c-fos in cisplatin-treated thyroid cells 36
P14/ARF-Positive Malignant Pleural Mesothelioma: A Phenotype With Distinct Immune Microenvironment 36
mTOR inhibition downregulates glucose-6-phosphate dehydrogenase and induces ROS-dependent death in T-cell acute lymphoblastic leukemia cells 36
Neoadjuvant Chemotherapy and Immunotherapy in Luminal B-like Breast Cancer: Results of the Phase II GIADA Trial 35
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway 33
PKC-ε-dependent cytosol-to-membrane translocation of pendrin in rat thyroid PC C13 cells 32
Targeted therapies in mesothelioma 29
Serum osteoprotegerin correlates with age and bone mass in postmenopausal, but not in fertile age women 20
Mesothelin-targeted agents in mesothelioma 19
[Pt(O,O′-acac)(γ-acac)(DMS)], a new Pt compound exerting fast cytotoxicity in MCF-7 breast cancer cells via the mitochondrial apoptotic pathway (British Journal of Pharmacology (2007) 153, (34-49) DOI: 10.1038/sj.bjp.0707646) 13
Repurposing Verapamil to Enhance Killing of T-ALL Cells by the mTOR Inhibitor Everolimus 9
Editorial: Moving beyond the molecular mechanisms of malignant pleural mesothelioma: Cues for novel biomarkers and drug targets 5
Totale 2.512
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.259
article - articoli 10.015
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 244
Totale 20.518
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201975 0 0 0 0 0 0 0 0 0 0 36 39
2019/2020326 26 9 11 63 22 14 21 38 48 29 29 16
2020/2021549 17 10 20 15 15 41 163 20 75 53 47 73
2021/2022724 40 44 38 15 74 198 35 33 43 68 37 99
2022/2023455 68 57 22 49 60 40 4 26 79 10 31 9
2023/2024247 17 42 41 23 12 42 22 3 10 35 0 0
Totale 2.512